Horizon Pharma (HZNP) Posts Q3 Loss of 39c/Share

Horizon Pharma (NASDAQ: HZNP) reported Q3 EPS of ($0.39), $0.29 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $4.12 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
• HSBC Upgrades Pegatron Corp. (4938:TT) to Hold